Myopia Management

Myopia management moves the ophthalmic industry. That is why the focus at opti is on the international exchange of knowledge on the treatment and control of myopia.

496 Following Show all

Posts - that's to be discovered on the topic (8)

CooperVision GmbH January 5, 2024
Expertise

Peer Review Paper Verifies MiSight® 1 day Six-Year Study Findings

Seminal Study Details Published in Ophthalmic and Physiological Optics, Affirming CooperVision Myopia Control Leadership, Companion Video Offers Highlights for ECPs.

opti 2024

mark´ennovy GmbH December 11, 2023
Product-Highlight

Mylo: a soft contact lens for comprehensive myopia management powered by the Brien Holden Vision Institute

Mylo, a soft contact lens granted on-label status for myopia management, now presents a comprehensive array of both spherical and toric powers. Mylo integrates cutting-edge Extended Depth of Focus (EDOF) technology to ensure outstanding visual performance, fostering both compliance and efficacy.

opti 2024

CooperVision GmbH November 28, 2023
Expertise

Pivotal International Seven-Year MiSight® 1 day Contact Lens Study Indicates No Myopia Control Rebound in Children

CooperVision, a world leader in myopia control and management for children, today announced new seven-year findings from its pivotal MiSight® 1 day contact lens clinical trial. Data Shows Eye Growth Slowed for All Tested Ages with Highly-Desired Proportional Treatment Effects.

opti 2024

CooperVision GmbH November 28, 2023
Product-Highlight

Small eyes, big responsibility

Together against myopia for the next generation: After a three-year break from opti, CooperVision, one of the world's leading manufacturers of soft contact lenses, will once again be represented with an exhibition stand at opti 2024, the International Trade Fair for Optics and Design in Munich.

opti 2024

Carl Zeiss Vision GmbH November 21, 2023
Product-Highlight

ZEISS Myopia Management in Europe

From April 2023, ZEISS solutions for the management of progressive myopia will also be available in Europe. Years of research show that prevalences differ and the risks associated with progressive myopia require specific solutions for different target groups.

opti 2024

Visall GmbH October 23, 2023
Product-Highlight

MYOSLOW - Get short-sightedness under control

Short-sightedness cannot be cured, but we can do something about it together. Our MYOSLOW concept helps you to advise your smallest customers in a completely product-independent way and to find joint approaches to solutions.

opti 2024

MPG & E Handel und Service GmbH September 25, 2023
Expertise

First 15 then 25 percent of all children and adolescents myopic

In Germany, around 15 percent of all children become myopic by the end of primary school. By the age of 25, the proportion of myopics and thus the risk of serious eye diseases rises to around 45 percent.

opti 2024

RODENSTOCK GMBH September 25, 2023
Product-Highlight

Rodenstock MyCon: The solution for children with myopia

Rodenstock MyCon lenses are designed to correct myopia, ensure sharp vision and counteract the progression of myopia in any nearsighted child, even preventively.

opti 2024

Exhibitors (6)